These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH AND Treatment
71 results:

  • 1. Outcomes with allogeneic stem cell transplant using cryopreserved versus fresh hematopoietic progenitor cell products.
    Wan BA; Lindo L; Mourad YA; Chung S; Forrest D; Kuchenbauer F; Nantel S; Narayanan S; Nevill T; Power M; Rodrigo J; Sanford D; Song K; Stubbins RJ; Sutherland H; Toze CL; White J; Roy C; Hay KA
    Cytotherapy; 2024 Oct; 26(10):1210-1216. PubMed ID: 38819367
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma-a randomized, open-label phase III trial of the European mantle cell lymphoma network.
    Fischer L; Jiang L; Dürig J; Schmidt C; Stilgenbauer S; Bouabdallah K; Solal-Celigny P; Scholz CW; Feugier P; de Wit M; Trappe RU; Hallek M; Graeven U; Hänel M; Hoffmann M; Delwail V; Macro M; Greiner J; Giagounidis AAN; Dargel B; Durot E; Foussard C; Silkenstedt E; Weigert O; Pott C; Klapper W; Hiddemann W; Unterhalt M; Hoster E; Ribrag V; Dreyling M
    Leukemia; 2024 Jun; 38(6):1307-1314. PubMed ID: 38678093
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The association of environmental factors with neurocognitive outcomes in survivors of childhood acute lymphoblastic leukemia (ALL).
    Nigro SE; Hall LP; Harman J; Willard VW; Conklin HM; Pui CH; Jeha S; Jacola LM
    Support Care Cancer; 2023 Dec; 32(1):1. PubMed ID: 38047975
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Spliceosome mutations are associated with clinical response in a phase 1b/2 study of the PLK1 inhibitor onvansertib in combination with decitabine in relapsed or refractory acute myeloid leukemia.
    Croucher PJP; Ridinger M; Becker PS; Lin TL; Silberman SL; Wang ES; Zeidan AM
    Ann Hematol; 2023 Nov; 102(11):3049-3059. PubMed ID: 37702821
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial.
    de Botton S; Montesinos P; Schuh AC; Papayannidis C; Vyas P; Wei AH; Ommen H; Semochkin S; Kim HJ; Larson RA; Koprivnikar J; Frankfurt O; Thol F; Chromik J; Byrne J; Pigneux A; Thomas X; Salamero O; Vidriales MB; Doronin V; Döhner H; Fathi AT; Laille E; Yu X; Hasan M; Martin-Regueira P; DiNardo CD
    Blood; 2023 Jan; 141(2):156-167. PubMed ID: 35714312
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Real-world treatment patterns and clinical outcomes in patients with AML unfit for first-line intensive chemotherapy
    Miyamoto T; Sanford D; Tomuleasa C; Hsiao HH; Olivera LJE; Enjeti AK; Gimenez Conca A; Castillo TBD; Girshova L; Martelli MP; Guvenc B; Delgado A; Duan Y; Garbayo Guijarro B; Llamas C; Lee JH
    Leuk Lymphoma; 2022 Apr; 63(4):928-938. PubMed ID: 35147482
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Health care utilisation following childhood acute lymphoblastic leukaemia: a population-based matched cohort study.
    Jensen KS; Klug Albertsen B; Schrøder H; Zalounina Falborg A; Schmiegelow K; Rosthøj S; Callesen MT; Vedsted P
    BMJ Open; 2021 Nov; 11(11):e049847. PubMed ID: 34810184
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Venetoclax plus low-dose cytarabine in Japanese patients with untreated acute myeloid leukaemia ineligible for intensive chemotherapy.
    Yamauchi T; Yoshida C; Usuki K; Takada S; Matsumura I; Dobashi N; Miyazaki Y; Miyamoto T; Iida H; Asou N; Kuroda J; Ichikawa S; Komatsu N; Mendes W; Honda H; Okubo S; Kurokawa M; Jiang Q; Wei A; Ishizawa K
    Jpn J Clin Oncol; 2021 Aug; 51(9):1372-1382. PubMed ID: 34322703
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Cost-Effectiveness of Tisagenlecleucel in Paediatric Acute Lymphoblastic Leukaemia (pALL) and Adult Diffuse Large B-Cell Lymphoma (DLBCL) in Switzerland.
    Moradi-Lakeh M; Yaghoubi M; Seitz P; Javanbakht M; Brock E
    Adv Ther; 2021 Jun; 38(6):3427-3443. PubMed ID: 34021886
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Fatigue Perpetuating Factors as Mediators of Change in a Cognitive Behavioral Intervention for Targeted Therapy-Related Fatigue in Chronic Myeloid leukemia: A Pilot Study.
    Hyland KA; Nelson AM; Eisel SL; Hoogland AI; Ibarz-Pinilla J; Sweet K; Jacobsen PB; Knoop H; Jim HSL
    Ann Behav Med; 2022 Feb; 56(2):137-145. PubMed ID: 33991085
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Severe hypercalcemia in a patient with chronic lymphocytic leukemia and non-small cell lung carcinoma: A case report.
    Shacham EC; Marshak DC; Brikman S; Dori G; Ishay A
    Medicine (Baltimore); 2021 Apr; 100(14):e24982. PubMed ID: 33832072
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Haploidentical hematopoietic stem cell transplantation for patients with myeloid sarcoma: a single center retrospective study.
    Yu WJ; Sun YQ; Han TT; Ye PP; Zhang XH; Xu LP; Liu KY; Yan CH; Huang XJ; Wang Y
    Ann Hematol; 2021 Mar; 100(3):799-808. PubMed ID: 33416901
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Erythrophagocytosis by blast cells and de novo T cell LAL without cytogenetic abnormalities in a Moroccan patient].
    Kahouli S; Zahid H; Khorassani ME; Kabbaj SE; Benkirane M; Messaoudi N
    Pan Afr Med J; 2020; 36():202. PubMed ID: 32963668
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Electrocardiographic characteristics of diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy.
    Chen Z; Lu K; Zhou L; Liu D; Li X; Han X; Tao H; Tse G; Zhang H; Liu T
    J Electrocardiol; 2020; 60():195-199. PubMed ID: 32413696
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Levothyroxine treatment is associated with an increased relative risk of overall and organ specific incident cancers - a cohort study of the Swedish population.
    Wändell P; Carlsson AC; Li X; Sundquist J; Sundquist K
    Cancer Epidemiol; 2020 Jun; 66():101707. PubMed ID: 32222650
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Phase I study of ibrutinib in Japanese patients with treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Shibayama H; Teshima T; Choi I; Hatake K; Sekiguchi N; Yoshinari N
    J Clin Exp Hematop; 2019; 59(4):179-186. PubMed ID: 31866619
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Every-other-day palonosetron plus aprepitant for prevention of emesis following induction chemotherapy for acute myeloid leukemia: A randomized, controlled study from the "Rete Ematologica Pugliese".
    Di Renzo N; Melillo L; Porretto F; Dargenio M; Pavone V; Pastore D; Mazza P; Mannina D; Merenda A; Cascavilla N; Greco G; Matera R; Bonizzoni E; Celio L; Musso M
    Cancer Med; 2020 Jan; 9(1):170-178. PubMed ID: 31725196
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Internet-assisted cognitive behavioral intervention for targeted therapy-related fatigue in chronic myeloid leukemia: Results from a pilot randomized trial.
    Jim HSL; Hyland KA; Nelson AM; Pinilla-Ibarz J; Sweet K; Gielissen M; Bulls H; Hoogland AI; Jacobsen PB; Knoop H
    Cancer; 2020 Jan; 126(1):174-180. PubMed ID: 31553815
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Computer-Aided Discovery of Massonianoside B as a Novel Selective DOT1L Inhibitor.
    Chen J; Park HJ
    ACS Chem Biol; 2019 May; 14(5):873-881. PubMed ID: 30951287
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Hematopoietic Cell Transplantation in Young Adult Acute Lymphoblastic leukemia: A United States Population-Level Analysis.
    Muffly L; Li Q; Alvarez E; Kahn J; Winestone L; Cress R; Penn DC; Keegan THM
    J Adolesc Young Adult Oncol; 2019 Jun; 8(3):254-261. PubMed ID: 30657424
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.